Saudi Arabia vs Togo: Share of people with HIV who receive antiretroviral therapy
Saudi Arabia
93.0%
in 2024
Togo
92.0%
in 2024
Saudi Arabia rank
11th
Togo rank
14th
Share of people with HIV who receive antiretroviral therapy over time
- Saudi Arabia
- Togo
How they compare
Saudi Arabia currently reports 93.0% against 92.0% in Togo, a difference of 1.0%.
Across all 25 years both countries report, Saudi Arabia has been ahead every year.
Saudi Arabia ranks 11th and Togo ranks 14th of 143 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saudi Arabia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.1% | 4.6% | 21.5% | Saudi Arabia |
| 2010s | 57.9% | 44.8% | 13.1% | Saudi Arabia |
| 2020s | 90.0% | 84.0% | 6.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Saudi Arabia or Togo?
- Saudi Arabia, at 93.0% against 92.0% in Togo as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Saudi Arabia and Togo?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and Togo?
- 25 years are reported by both, from 2000 to 2024.
- How do Saudi Arabia and Togo rank globally for share of people with hiv who receive antiretroviral therapy?
- Saudi Arabia ranks 11th and Togo ranks 14th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.